Aptose Biosciences Inc

NASDAQ: APTO    
Share price (5/3/24): $1.19    
Market cap (5/3/24): $18.7 million
Search in Documents
Key Exhibits
External Links

Transcripts

CY 2024
Earnings Revised 03/26/24 Aptose Biosciences Inc., Q4 2023 Earnings Call, Mar 26, 2024 03/26/24
CY 2023
Earnings Revised 01/11/24 Aptose Biosciences Inc., Q3 2023 Earnings Call, Nov 09, 2023 11/09/23 Other Revised 12/13/23 Aptose Biosciences Inc. - Special Call 10/30/23 Earnings Revised 08/10/23 Aptose Biosciences Inc., Q2 2023 Earnings Call, Aug 10, 2023 08/10/23 Other Revised 07/19/23 Aptose Biosciences Inc. - Special Call 06/10/23 Other Revised 05/23/23 Aptose Biosciences Inc. - Shareholder/Analyst Call 05/23/23 Earnings Revised 05/09/23 Aptose Biosciences Inc., Q1 2023 Earnings Call, May 08, 2023 05/08/23 Earnings Revised 03/23/23 Aptose Biosciences Inc., Q4 2022 Earnings Call, Mar 23, 2023 03/23/23
CY 2022
Other Revised 12/11/22 Aptose Biosciences Inc. - Special Call 12/11/22 Earnings Revised 11/01/22 Aptose Biosciences Inc., Q3 2022 Earnings Call, Nov 01, 2022 11/01/22 Earnings Revised 08/02/22 Aptose Biosciences Inc., Q2 2022 Earnings Call, Aug 02, 2022 08/02/22 Other Revised 06/02/22 Aptose Biosciences Inc. - Special Call 06/02/22 Other Revised 05/31/22 Aptose Biosciences Inc. - Shareholder/Analyst Call 05/31/22 Earnings Revised 05/09/22 Aptose Biosciences Inc., Q1 2022 Earnings Call, May 09, 2022 05/09/22 Earnings Revised 03/22/22 Aptose Biosciences Inc., Q4 2021 Earnings Call, Mar 22, 2022 03/22/22
CY 2021
Other Revised 12/13/21 Aptose Biosciences Inc. - Special Call 12/13/21 Earnings Revised 11/11/21 Aptose Biosciences Inc., Q3 2021 Earnings Call, Nov 11, 2021 11/11/21 Other Revised 11/04/21 Aptose Biosciences Inc. - Special Call 11/04/21 Earnings Revised 08/03/21 Aptose Biosciences Inc., Q2 2021 Earnings Call, Aug 03, 2021 08/03/21 Other Revised 06/11/21 Aptose Biosciences Inc. - Special Call 06/11/21 Other Revised 06/02/21 Aptose Biosciences Inc. Presents at Jefferies 2021 Virtual Healthcare Conference, Jun-02-2021 02:00 PM 06/02/21 Other Revised 06/01/21 Aptose Biosciences Inc. - Shareholder/Analyst Call 06/01/21 Earnings Revised 05/04/21 Aptose Biosciences Inc., Q1 2021 Earnings Call, May 04, 2021 05/04/21 Earnings Revised 03/23/21 Aptose Biosciences Inc., Q4 2020 Earnings Call, Mar 23, 2021 03/23/21
CY 2020
Other Revised 12/06/20 Aptose Biosciences Inc. - Special Call 12/06/20 Earnings Revised 11/10/20 Aptose Biosciences Inc., Q3 2020 Earnings Call, Nov 10, 2020 11/10/20 Earnings Revised 08/04/20 Aptose Biosciences Inc., Q2 2020 Earnings Call, Aug 04, 2020 08/04/20 Other Revised 06/02/20 Aptose Biosciences Inc. - Shareholder/Analyst Call 06/02/20 Earnings Revised 05/05/20 Aptose Biosciences Inc., Q1 2020 Earnings Call, May 05, 2020 05/05/20 Earnings Revised 03/10/20 Aptose Biosciences Inc., Q4 2019 Earnings Call, Mar 10, 2020 03/10/20 Other Revised 02/05/20 Aptose Biosciences Inc. - Special Call 02/05/20
CY 2019
Earnings Revised 11/05/19 Aptose Biosciences Inc., Q3 2019 Earnings Call, Nov 05, 2019 11/05/19 Earnings Revised 08/06/19 Aptose Biosciences Inc., Q2 2019 Earnings Call, Aug 06, 2019 08/06/19 Earnings Revised 05/07/19 Aptose Biosciences Inc., Q1 2019 Earnings Call, May 07, 2019 05/07/19 Earnings Revised 03/12/19 Aptose Biosciences Inc., Q4 2018 Earnings Call, Mar 12, 2019 03/12/19
CY 2018
Other Revised 12/12/18 Aptose Biosciences Inc. - Special Call 12/12/18 Earnings Revised 11/07/18 Aptose Biosciences Inc., Q3 2018 Earnings Call, Nov 07, 2018 11/07/18
CY 2008
Other Revised 09/09/08 Lorus Therapeutics Inc. - Conference Presentation Call 09/09/08